XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
MARKETABLE SECURITIES (Details Narrative)
$ / shares in Units, € in Millions
 1 Months Ended 6 Months Ended
Jul. 16, 2018
USD ($)
shares
May 17, 2018
USD ($)
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2022
CAD ($)
shares
Jun. 30, 2022
EUR (€)
shares
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Jun. 30, 2019
Net unrealized loss on fair value investment     $ 56          
Equity securities - Pancreta Bank [Member]                
Additional investments in equity securities     $ 5,407          
Marathon Global Inc. [Member] | Distribution And Equity Acquisition Agreement [Member]                
Equity interest acquired description     a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services      
Cash received upon gross sales       $ 2,750,000        
Gross sales       6,500,000        
Marathon Global Inc. [Member] | Distribution And Equity Acquisition Agreement [Member] | Sales One [Member]                
Cash received upon gross sales       2,750,000        
Gross sales       $ 13,000,000        
National Bank of Greece [Member]                
Equity method investment shares acquired, value     $ 6,822          
Equity method investment shares acquired, shares | shares     16,666 16,666 16,666      
Closing price | $ / shares     $ 0.30          
Cosmo Farmacy LP [Member]                
Cash contributed to limited partner | €         € 150,000      
Initial share capital increased | €         500,000      
Pharmacy license value | €         € 350,000      
Maturity period of license     30 years 30 years 30 years      
Ownership equity               70.00%
Initial share capital | €         € 150,000      
Equity ownership remaining               30.00%
Investments     $ 157,035       $ 169,770  
Share Exchange Agreement [Member] | Equity securities - Pancreta Bank [Member]                
Additional investments in equity securities     5,407          
Share Exchange Agreement [Member] | Marathon Global Inc. [Member]                
Gain on exchange of investment $ 2,092,200 $ 1,953,000            
Shares of Marathon transferred by company to KBB | shares 2,500,000              
Share Exchange Agreement [Member] | Kaneh Bosm Biotechnology Inc [Member]                
Transfer of shares | shares   2,500,000            
Share Exchange Agreement [Member] | Kaneh Bosm Biotechnology Inc [Member] | Canadian Securities Exchange [Member]                
Exchange of shares | shares   5,000,000            
Share Exchange Agreement [Member] | ICC [Member]                
Net unrealized loss on fair value investment           $ 0    
Investments     $ 0       $ 0  
Exchange of shares | shares 5,000,000              
Description for ownership percentage The ten million shares of ICC owned by the Company constituted approximately 7% of the 141,219,108 shares of capital stock of KBB then issued and outstanding. The Company does not have the ability to exercise significant influence over ICC.   Since no value was attributed to the 33 1/3% equity ownership interest in Marathon received as consideration for the distribution services, the Company would receive variable consideration in the future for its services under the Distribution and Equity Acquisition Agreement Since no value was attributed to the 33 1/3% equity ownership interest in Marathon received as consideration for the distribution services, the Company would receive variable consideration in the future for its services under the Distribution and Equity Acquisition Agreement Since no value was attributed to the 33 1/3% equity ownership interest in Marathon received as consideration for the distribution services, the Company would receive variable consideration in the future for its services under the Distribution and Equity Acquisition Agreement      
Additional shares issued, amount | shares     0          
Additional shares issued, shares | shares     3,000,000          
Share Exchange Agreement [Member] | National Bank of Greece [Member]                
Equity method investment shares acquired, value     $ 4,925          
Equity method investment shares acquired, shares | shares     16,666 16,666 16,666      
Closing price | $ / shares     $ 0.30